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Introduction {#s1}
============

Phthalates and bisphenols are synthetic compounds incorporated in many products. For example, phthalates such as di-(2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), di-*n*-octyl phthalate (DNOP), and benzyl butyl phthalate (BBP) are primarily used as plasticizers for polyvinyl chloride and exist in food packaging materials, floor materials, clothing, toys, and medical devices. DBPs are also used as solvents and fixatives in paint and cosmetics ([@c24]; [@c106]; [@c108]). Bisphenol A (BPA) or common replacements such as bisphenol S (BPS) and bisphenol F (BPF) exist in products such as epoxy resin coatings of canned food containers, water bottles, storage containers, thermal paper, and baby bottles ([@c72]; [@c84]).

Phthalates and bisphenols are omnipresent in the environment, and these compounds have been detected in urine samples of mothers and their offspring ([@c22]). Prenatal exposure to these chemicals can occur because of their ability to cross the placental and blood--brain barriers ([@c137]; [@c138]; [@c134]; [@c136]). Studies suggest that prenatal phthalate and bisphenol exposure both interfere with the thyroid hormone system ([@c10]; [@c13]; [@c40]; [@c42]; [@c79]; [@c86]), which is crucial for normal fetal brain development ([@c9]). In addition, neurotoxic effects of phthalates and bisphenols may be mediated by anti-androgenic activity ([@c14]; [@c38]; [@c125]; [@c127]), disruption of brain dopaminergic activity ([@c8]; [@c49]; [@c114]), and interaction with peroxisome proliferator-activated receptors ([@c52]; [@c79]; [@c86]).

Studies in animals have shown that prenatal phthalate and bisphenol exposure impairs neurodevelopment in the offspring ([@c3]; [@c11]; [@c63]; [@c75]; [@c76]; [@c98]; [@c112]; [@c114]; [@c120]; [@c127]; [@c130]). With respect to phthalates, animal studies find inverse associations between prenatal exposure to DEHP and DBP and learning, memory, and brain development in the offspring ([@c3]; [@c11]; [@c75]; [@c76]; [@c114]). In addition, prenatal exposure to DEHP can affect developmental plasticity of the hippocampus ([@c112]). Regarding bisphenols, animal studies have shown that gestational exposure to BPA was associated with alterations in brain morphology and brain function ([@c127]). Further, BPA-exposed rats and mice exhibit persistent learning and memory impairments ([@c98]; [@c120]; [@c130]) and low-dose BPA exposure disrupts hippocampal CA1 neuronal morphology, which is believed to persist into adulthood ([@c63]; [@c120]; [@c130]).

However, epidemiological studies investigating the associations between prenatal phthalate or bisphenol exposure and cognitive functioning in children are limited and the findings are inconclusive. One study using mother--child pairs from inner-city New York reported that higher metabolite concentrations of DBP and di-isobutyl phthalate metabolites measured in the third trimester were associated with lower intelligent quotient (IQ) score in 328 children at 7 years of age ([@c37]). Similarly, other studies ($n = 150–417$) found that higher levels of DEHP metabolites during the third trimester were associated with a lower score on the mental development index (MDI) of the Bayley Scales of Infant Development at 0.5--2 years of age ([@c62]; [@c100]). Two studies found that third-trimester concentrations of DBP and mono(3-carboxypropyl) phthalate (mCPP) metabolites were inversely associated with the MDI at child age 2--3 y, but only in girls ([@c33]; [@c126]). Another study found the averaged sum of high-molecular weight phthalates (HMWPs) and DEHP exposure across pregnancy to be inversely associated with IQ, but only in boys ([@c51]). Yet, five other studies did not find any association between prenatal exposure to phthalates and cognition during the second ([@c61]; [@c74]) and third trimester ([@c50]; [@c74]; [@c93]; [@c99]) using data from 100--452 mother--child pairs. Research on bisphenol exposure mostly found little evidence of an association between prenatal exposure and child cognition. One study found an inverse association between prenatal BPA exposure measured in cord blood and offspring IQ at 7 years of age in 148 children ([@c77]). However, most other studies using maternal urine concentrations to determine exposure did not show an association between prenatal BPA exposure and cognitive functioning in 239--812 children at 1--8 years of age ([@c15], [@c16], [@c18]; [@c23]; [@c93]; [@c110]). Further, a recent study found first trimester exposure to a mixture of 26 endocrine-disrupting chemicals to be associated with lower IQ among boys ([@c115]). Among a broad range of chemical biomarkers, the present study included phthalate metabolites and BPA, BPF, and BPS and identified BPF as the primary chemical of concern. In addition, concentrations of BPA, mono-ethyl phthalate (mEP), and monobenzyl phthalate (mBzP) had a considerable contribution to the overall mixture effect ([@c115]).

The heterogeneity in epidemiological results may be explained by the fact that most of these studies had modest sample sizes, which may have limited the statistical power to consistently detect adverse associations. In addition, most studies measured prenatal exposure only during the third trimester, whereas other windows of susceptibility may exist ([@c109]). Finally, only one previous study investigated the association between prenatal exposure to BPS and BPF with IQ. To address these limitations, we studied a large cohort from the Generation R Study, which is characterized by detailed follow-up information of the child and three repeated measurements (early, mid, and late pregnancy) of urinary phthalate and bisphenol biomarkers, including BPF and BPS. We investigated the extent to which maternal exposure to phthalates or bisphenols during pregnancy are associated with offspring's nonverbal IQ at 6 years of age.

Methods {#s2}
=======

Study Participants and Follow-Up {#s2.1}
--------------------------------

Generation R is a prospective population-based birth cohort designed to identify early environmental and genetic determinants of growth and development ([@c67]). Briefly, all pregnant women who resided in the study area in Rotterdam, Netherlands, and had a delivery date between April 2002 and January 2006 were eligible. All eligible pregnant women who visited a midwife or obstetrician in Rotterdam were contacted by the Generation R Study staff for recruitment. The study staff were able to communicate with the pregnant women in Dutch, English, French, Portuguese, and Turkish. Among the 9,778 mothers who participated in the study, 8,879 (91%) were enrolled during pregnancy and the rest were enrolled during routine visits of the newborn to the child health centers. The enrollment procedure has been previously described in detail ([@c46]; [@c53], [@c55], [@c56], [@c54]). Between February 2004 and January 2006, women provided spot urine specimens at the time of routine ultrasound examinations during early, mid, and late pregnancy. A total of 2,083 women provided a complete set of three urine specimens.

When the children turned 6 years of age, the families were invited to participate in an in-person follow-up visit to collect neurobehavioral data, biospecimens, and sociodemographic and health data. Of the 2,083 mother--child pairs with three urinary samples, 1,405 provided data at 6 years of age of the child. The availability of follow-up data was a requirement to allow studies of the associations between prenatal phthalates and bisphenol exposure and child health, including cognition. Of these 1,405 mother--child pairs, 1,282 had complete data on nonverbal IQ and comprised the study sample. Women in this subset had higher education and income levels, were slightly older, and were more likely to be of Dutch national origin than the broader Generation R cohort ([@c67]).

The study protocol underwent human subjects review at Erasmus Medical Center, Rotterdam, Netherlands (MEC 198.782.2001.31, MEC-2007-413). Mothers provided written informed consent for themselves and their children.

Bisphenol and Phthalate Measurements in Urine {#s2.2}
---------------------------------------------

Maternal spot urine specimens were collected during early ($\text{mean} = 13.3\text{ wks}$ of gestation, $\text{range} = 6.5–17.9\text{ wks}$), mid ($\text{mean} = 20.4\text{ wks}$ of gestation, $\text{range} = 18.1–24.9\text{ wks}$), and late pregnancy ($\text{mean} = 30.3\text{ wks}$ of gestation, $\text{range} = 27.4–34.5\text{ wks}$). Details on urine specimen collection have been described elsewhere ([@c69]). Briefly, all urine samples were collected (at 0800--1000 hours) in $100\text{-mL}$ polypropylene urine collection containers that were kept for a maximum of 20 h in a cold room (4°C) before being frozen at $- 20{^\circ}C$ in $20\text{-mL}$ aliquots in $25\text{-mL}$ polypropylene vials. The urine specimens were shipped on dry ice in $4\text{-mL}$ polypropylene vials to the Wadsworth Center, New York State Department of Health, Albany, New York, for analysis of phthalate metabolite and bisphenol concentrations.

A detailed description of the analytical procedure is given elsewhere ([@c97]). Briefly, quantitative detection of phthalate metabolites was achieved by using a solid-phase extraction method followed by enzymatic deconjugation of the glucuronidated phthalate monoesters coupled with high performance liquid chromatography electrospray ionization--tandem mass spectrometry (HPLC-ESI-MS/MS) ([@c4]), which allowed for the rapid detection of 18 metabolites of phthalates with limits of detection (LODs) in the range of $0.008–0.89\text{ ng}/{mL}$. Quantitative detection of bisphenols was realized using a liquid--liquid extraction method followed by enzymatic deconjugation of the glucuronidated bisphenols coupled with HPLC-ESI-MS/MS, which permitted the detection of eight biomarkers of bisphenols (including BPA, BPF, and BPS) with an LOD range of $0.03–0.79\text{ ng}/{mL}$. Similarly, samples were analyzed for creatinine using HPLC-ESI-MS/MS. Quantification of calibration check standards resulted in an LOD of $0.30\text{ ng}/{mL}$.

Exposure biomarkers were excluded from further statistical analyses if more than 80% of the study population had concentrations below the LOD. Urinary biomarkers for exposure to phthalates were grouped according to their parent compound, biologic activity, and source of exposure in order to limit multiple comparisons. Phthalate groups included low-molecular weight phthalates (LMWPs), HMWPs, DEHP, DNOP, and phthalic acid (PA). For the LMWP group, we summed mono-methyl phthalate (mMP), mEP, mono-*n*-butyl phthalate (mBP), and mono-isobutyl phthalate (mIBP) metabolite concentrations. For the HMWP group, we summed mono-(2-ethyl-5-carboxypentyl) phthalate (mECPP), mono-(2-ethyl-5-hydroxyhexyl) phthalate (mEHHP), mono-(2-ethyl-5-oxohexyl) phthalate (mEOHP), mono-\[(2-carboxymethyl)hexyl\] phthalate (mCMHP), mCPP, mBzP, mono-hexyl phthalate (mHxP), and mono-2-heptyl phthalate (mHpP) metabolite concentrations. For the DEHP group, we summed mECPP, mEHHP, mEOHP, and mCMHP metabolite concentrations and used MCPP metabolite concentrations as a proxy for DNOP exposure. Finally, PA is an end metabolite of all phthalates. PA metabolite concentrations were therefore analyzed separately as a proxy for total phthalate exposure. Regarding bisphenol concentrations, we calculated the sum for total bisphenol concentrations. Prior to the statistical analyses, all concentrations below the LOD were replaced with the LOD divided by the square root of 2 ([@c47]).

Nonverbal IQ at Child Age 6 Years {#s2.3}
---------------------------------

Children's nonverbal IQ was assessed by administering the Mosaics and Categories subtests from the Snijders-Oomen Nonverbal Intelligence Test--Revised (SON-R), a reliable and well-validated instrument ([@c57]; [@c87]; [@c116]). The correlation between the total score of the SON-R 2.5-7 and the performance IQ score of the Wechsler Preschool and Primary Scale of Intelligence has been reported to be between 0.60 and 0.83, and the average reliability of the SON-R $2½–7$ IQ score was 0.90 ([@c57]; [@c87]; [@c117]). Further, the test is regarded as highly reliable and rated good (3 of 3) by the commission of Netherlands Institute for Psychologists. The two language-independent subtests that included items that probe visuospatial and abstract reasoning abilities were selected because of the multiethnic composition of the Generation R Study. Subtest raw test scores were converted into age-standardized nonverbal IQ scores. These standardized scores, based on the two subtests, correlated well ($r = 0.86$) with those based on the complete instrument ([@c41]).

Additional Data Collection {#s2.4}
--------------------------

Maternal reproductive, sociodemographic, and cognitive data were assessed by questionnaires and/or observations. During the first prenatal visit, height, and weight were measured, but prepregnancy weight was self-reported by participants. These data were used to calculate body mass index (BMI). In addition, data was collected on maternal age (years), parity (0, 1, or $\geq 2$), smoking (no smoking during pregnancy, smoking until pregnancy recognized, and continued smoking during pregnancy), alcohol intake during pregnancy \[no alcohol consumption during pregnancy, alcohol consumption until pregnancy recognized, continued occasionally ($< 1\text{ glass}/\text{wk}$), and continued frequently ($\geq 1\text{ glass}/\text{wk}$)\], marital status (married/partner or single), household total net income \[$< 1,200\text{ euros}/\text{month}$ (i.e., below the Dutch social security level), 1,200--2,000 euros/month, $> 2,000\text{ euros}/\text{month}$\], highest completed education level \[low ($< 3\; y$ at general secondary school) intermediate ($\geq 3\; y$ of secondary education), and high (university degree or higher vocational training)\], ethnicity (Dutch national origin, other-Western, and non-Western), and folic acid intake (none, started in first 10 wks of pregnancy, and started preconception). Maternal IQ was examined when mother--child pairs attended the 6-y examination and was assessed using a computerized Ravens Advanced Progressive Matrices Test, Set I ([@c83]). The test is a 12-item reliable and validated short version of the Raven's Progressive Matrices to assess nonverbal cognitive ability ([@c26]). The consumption of fruit and vegetables was assessed in the first trimester using a modified version of a validated food frequency questionnaire and was adjusted for energy intake ([@c111]). Except for BMI (12%), smoking (10%), income (15%), folic acid intake (21%), and fruit and vegetable intake (25%), the percentage of missing values was below 10%.

Statistical Methods {#s2.5}
-------------------

Urinary phthalate metabolite and bisphenol concentrations were expressed on a creatinine basis and $\log_{10}$ transformed (in micrograms per gram creatinine). Missing phthalate metabolite and bisphenol concentration values ($n = 13$ with missing data in one or two urinary collection periods during pregnancy) and all missing covariate data were imputed 10 times with the multivariate imputation by chained equations method in R (version 3.5.3; R Development Core Team) ([@c122]). Urinary BPA and PA metabolite concentrations and the child nonverbal IQ score were included as predictors for the imputation of covariates. The outcome variable child nonverbal IQ was not imputed. We calculated intraclass correlation coefficients (ICCs) for individual measurements, for example, during early pregnancy (single-rater, relevant to the time-specific analyses), and for the mean of the three measurements across pregnancy (mean of *k* raters), using two-way mixed-effects models with absolute agreement ([@c66]). Further, we first performed regression analyses to estimate the associations of grouped phthalate and bisphenol urinary concentrations with nonverbal IQ for each collection phase (gestational age $< 18$, 18--25, and $> 25\text{ wks}$). Second, a mutually adjusted model was fitted in which the association of prenatal phthalate and bisphenol urinary concentrations from each time period on nonverbal IQ were jointly estimated. To test whether the association between prenatal urinary concentrations of phthalate metabolites and bisphenols and nonverbal IQ differed across time windows of exposure ($p_{\text{interaction}} < 0.1$), we used the multiple informant method, in which different exposure windows are treated as informants ([@c105]). We chose this strategy to identify possible windows of susceptibility and to be able to compare our results with other studies that used a single spot urine sample in pregnancy to determine phthalate and bisphenol concentrations. Third, we carried out regression analyses to estimate the association between the averaged prenatal urinary concentrations across pregnancy and nonverbal IQ. Urinary metabolite concentrations of phthalates and (especially) bisphenol concentrations vary over time. Therefore, the average is most likely a better approximation of each participant's exposure during pregnancy than any exposure measurement on its own. Fourth, we presented restrictive cubic splines for untransformed grouped biomarker concentrations that were predictive of nonverbal IQ. Finally, several studies have suggested that sex may be a potential effect estimate modifier in the association of prenatal exposure to phthalates and bisphenols and neurodevelopmental outcomes ([@c15]; [@c23]; [@c33]; [@c37]; [@c51]; [@c62]; [@c110]; [@c126]). We therefore explored potential effect modification by sex via stratification, interaction terms, and augmented product terms ([@c19]) ($p_{\text{interaction}} < 0.05$).

We present results from unadjusted and adjusted analyses. The adjustment variables were maternal age (continuous), ethnicity (categorical), education (categorical), income (categorical), marital status (categorical), alcohol consumption during pregnancy (categorical), maternal nonverbal IQ (continuous), prepregnancy BMI (continuous), parity (categorical), smoking during pregnancy (categorical), child sex (categorical), and child age at assessment (continuous). These potential confounders were selected *a priori* defined with a directed acyclic graph (DAG) ([@c119]) based on previous studies of prenatal phthalate and bisphenol exposure and child neurodevelopment and on biologically plausible covariate--exposure and covariate--outcome associations observed in our data (see Figure S1).

Sensitivity Analyses {#s2.6}
--------------------

Several sensitivity analyses were performed. First, we used another common method to adjust for creatinine by refitting visit-specific and averaged models, with concentrations expressed in nanograms per milliliter and creatinine concentration added as a separate covariate. We performed this sensitivity analyses to facilitate comparison with previous studies investigating prenatal exposure to nonpersistent chemicals and neurodevelopment that have used this adjustment method. Second, we performed post hoc analyses in which we explored the associations of individual phthalate metabolite and bisphenol concentrations with nonverbal IQ because individual phthalates and bisphenols within the summed groups may have different neurotoxic effects. Third, we used inverse probability weighting (stabilized weights) to correct for potential selection bias ([@c135]) and to provide results representative for the full Generation R Study cohort ($n = 9,901$) given that children included in the analysis ($n = 1,282$) were more likely to have parents who were of Dutch national origin, older, and from a higher socioeconomic ([@c67]). Baseline characteristics significantly different ($p < 0.20$) between the initially recruited cohort and the current analysis sample are presented in Table S1. Fourth, because diet and the intake of healthy nutrients may confound the association between prenatal phthalate and bisphenol exposure (e.g., food packaging) and child cognition (e.g., healthy nutrients), we performed a sensitivity analyses in which we additionally adjusted for maternal fruit, vegetables, and folic acid intake. Fifth, to correct for multiple hypothesis testing, each $p$-value was compared with a threshold, defined as 0.05 divided by the effective independent number of tests ([@c73]). The corrected $p$-value was calculated based on the correlation structure between the phthalate metabolite groups (LMWP, HMWP, DEHP, DNOP, and PA) for each time point separately (corrected $p < 18\text{ wks\ of\ gestation} = 0.02$, $18–25\text{ wks\ of\ gestation} = 0.018$, $> 25\text{ wks\ of\ gestation} = 0.017$), and for the average exposures (corrected $p = 0.017$).

Results {#s3}
=======

Sample Characteristics {#s3.1}
----------------------

At enrollment, most of the participating women were between 30 and 35 years of age (43%), nulliparous (61%), Dutch (54%), married (89%), and highly educated (50%) ([Table 1](#t1){ref-type="table"}). A large group had a prepregnancy BMI of between 18.5 and 25 (70%), a high income (68%), and did not consume alcoholic beverages (42%) or smoke (75%) during pregnancy.

###### 

Characteristics of study participants ($n = 1,282$).

Table 1 has 5 main columns, namely, Maternal characteristics superscript a, Percentages, Phthalic acid superscript b, Bisphenols superscript c, and Nonverbal intelligence quotient superscript d. Phthalic acid superscript b and bisphenols superscript c have two subcolumns, namely, median and P25, P75. Nonverbal intelligence quotient superscript d has one subcolumn, namely, mean plus or minus standard deviation.

  Maternal characteristics[^*a*^](#TF2){ref-type="table-fn"}   Percentages   Phthalic acid[^*b*^](#TF3){ref-type="table-fn"}   Bisphenols[^*c*^](#TF4){ref-type="table-fn"}   Nonverbal IQ[^*d*^](#TF5){ref-type="table-fn"}              
  ------------------------------------------------------------ ------------- ------------------------------------------------- ---------------------------------------------- ------------------------------------------------ ---------- -----------------------------
  Age (y)                                                                                                                                                                                                                                 
   $< 20$                                                      2.0           109.2                                             65.4, 162.5                                    1.5                                              1.2, 2.6   $94 \pm 15$
   $20– < 25$                                                  11.5          85.5                                              61.9, 123.9                                    1.7                                              1.1, 2.8   $94 \pm 14$
   $25– < 30$                                                  26.8          82.6                                              52.1, 129.7                                    1.7                                              1.1, 2.8   $102 \pm 15$
   $30– < 35$                                                  42.9          84.7                                              52.5, 131.8                                    1.9                                              1.3, 2.9   $104 \pm 16$
   $\geq 35$                                                   16.8          85.8                                              54.5, 135.5                                    1.9                                              1.1, 2.9   $104 \pm 13$
  Prepregnancy BMI (${kg}/m^{2}$)                                                                                                                                                                                                         
   $< 18.5$                                                    2.5           88.6                                              45.4, 123.5                                    1.9                                              1.3, 3.1   $102 \pm 16$
   $18.5– < 25$                                                69.8          79.9                                              51.1, 124.3                                    1.8                                              1.1, 2.8   $103 \pm 15$
   $25– < 30$                                                  19.1          95.6                                              58.2, 146.0                                    2.1                                              1.3, 3.3   $100 \pm 15$
   $\geq 30$                                                   8.6           95.0                                              67.7, 142.0                                    1.8                                              1.2, 3.0   $98 \pm 17$
  Parity                                                                                                                                                                                                                                  
   0                                                           60.5          86.0                                              54.0, 133.9                                    1.8                                              1.2, 2.8   $103 \pm 15$
   1                                                           28.2          79.9                                              52.5, 119.3                                    1.9                                              1.2, 3.0   $102 \pm 15$
   $\geq 2$                                                    11.3          88.2                                              54.2, 139.8                                    1.7                                              1.1, 2.8   $98 \pm 15$
  Ethnicity                                                                                                                                                                                                                               
   Dutch                                                       53.9          81.1                                              50.4, 131.8                                    1.9                                              1.2, 2.9   $106 \pm 15$
   Other-Western                                               12.4          78.2                                              52.9, 128.6                                    1.7                                              1.2, 2.5   $102 \pm 14$
   Non-Western                                                 33.7          88.3                                              58.7, 132.9                                    1.8                                              1.1, 2.9   $96 \pm 15$
  Education[^*e*^](#TF6){ref-type="table-fn"}                                                                                                                                                                                             
   Low                                                         18.9          95.2                                              65.0, 151.7                                    1.8                                              1.2, 2.8   $96 \pm 15$
   Intermediate                                                30.7          85.9                                              55.3, 137.0                                    1.9                                              1.2, 3.1   $100 \pm 14$
   High                                                        50.4          76.2                                              48.8, 122.1                                    1.8                                              1.1, 2.8   $106 \pm 14$
  Household income (euros/month)                                                                                                                                                                                                          
   $< 1,200$                                                   15.4          91.1                                              62.4, 135.9                                    1.6                                              1.1, 2.8   $95 \pm 15$
   1,200--2,000                                                17.0          86.9                                              56.2, 137.3                                    1.9                                              1.3, 3.0   $100 \pm 15$
   $> 2,000$                                                   67.6          81.2                                              50.7, 127.4                                    1.8                                              1.2, 2.9   $105 \pm 14$
  Marital status                                                                                                                                                                                                                          
   Married/living with partner                                 88.5          82.8                                              52.0, 128.9                                    1.8                                              1.2, 2.9   $103 \pm 15$
   No partner                                                  11.5          96.2                                              67.7, 151.0                                    1.8                                              1.1, 3.1   $99 \pm 15$
  IQ score                                                                                                                                                                                                                                
   $\leq 85$                                                   22.5          91.3                                              58.3, 145.5                                    1.9                                              1.1, 2.9   $96 \pm 15$
   $> 85– \leq 100$                                            43.3          86.9                                              55.6, 134.8                                    1.8                                              1.2, 2.7   $102 \pm 14$
   $> 100– < 115$                                              17.9          79.3                                              50.8, 125.2                                    1.8                                              1.2, 2.8   $105 \pm 14$
   $\geq 115$                                                  16.3          72.9                                              47.3, 118.6                                    1.9                                              1.3, 3.1   $107 \pm 16$
  Smoking                                                                                                                                                                                                                                 
   No smoking during pregnancy                                 75.3          78.7                                              51.5, 122.7                                    1.8                                              1.1, 2.8   $103 \pm 15$
   Until pregnancy recognized                                  10.2          97.6                                              62.8, 140.1                                    2.0                                              1.4, 3.2   $101 \pm 14$
   Continued during pregnancy                                  14.5          105.6                                             71.2, 154.8                                    1.9                                              1.2, 3.1   $97 \pm 15$
  Alcoholic beverage consumption                                                                                                                                                                                                          
   No alcohol consumption                                      42.1          86.5                                              56.6, 137.6                                    1.8                                              1.1, 2.8   $99 \pm 15$
   Until pregnancy recognized                                  17.0          78.5                                              52.4, 132.7                                    1.7                                              1.1, 2.7   $103 \pm 14$
   Continued occasionally[^*f*^](#TF7){ref-type="table-fn"}    35.2          85.5                                              51.3, 124.9                                    2.0                                              1.3, 3.0   $105 \pm 16$
   Continued frequently[^*g*^](#TF8){ref-type="table-fn"}      5.8           74.6                                              48.1, 129.7                                    2.0                                              1.4, 3.1   $105 \pm 14$
  Infant characteristics                                       Percentages   Median                                            P25, P75                                       Median                                           P25, P75   $\text{Mean} \pm \text{SD}$
  Sex of infant at birth                                                                                                                                                                                                                  
   Male                                                        50.5          84.5                                              52.6, 130.7                                    1.9                                              1.2, 3.0   $102 \pm 16$
   Female                                                      49.5          84.1                                              53.7, 132.3                                    1.7                                              1.2, 2.7   $101 \pm 15$

Note: BMI, body mass index; IQ, intelligence quotient; P, percentile; SD, standard deviation.

There were missing observations for BMI ($n = 157$), parity ($n = 8$), ethnicity ($n = 13$), education ($n = 60$), household income ($n = 193$), marital status ($n = 69$), maternal IQ ($n = 34$), smoking ($n = 132$), and alcohol consumption ($n = 91$).

Average total phthalic acid in micrograms per gram creatinine by category of characteristics.

Average total bisphenols in micrograms per gram creatinine by category of characteristics.

Nonverbal IQ by category of characteristics.

Low: no education finished, primary education, lower vocational training, intermediate general school or $< 3\; y$ at general secondary school. Intermediate: $\geq 3\; y$ of secondary education, intermediate vocational training or first year of higher vocational training. High: University degree or higher vocational training.

Less than 1 glass/wk.

One or more glasses/wk for at least two trimesters.

Phthalate and Bisphenol Concentrations {#s3.2}
--------------------------------------

The median LMWP metabolite concentrations for $< 18$, 18--25, and $> 25\text{ wks}$ of gestation were 240, 103, and $232\;\mu g/g$ creatinine, respectively ([Table 2](#t2){ref-type="table"}). The median HMWP measured at $< 18$, 18--25, and $> 25\text{ wks}$ of gestation were 69, 33, and $52\;\mu g/g$ creatinine. Total bisphenol concentrations comprised mostly BPA, and the median total bisphenol concentrations for $< 18$, 18--25, and $> 25\text{ wks\ of\ gestation}$ were 2, 1, and $2\;\mu g/g$ creatinine, respectively. Descriptive statistics of the individual biomarkers from our study sample can be found in Tables S2 and S3. The ICC for the grouped phthalate metabolite concentrations varied between 0.2 and 0.4 for a single measurement and varied between 0.4 and 0.6 for the mean of the three measurements (see Table S4). Regarding the bisphenol group, the ICCs for a single-measurement (0.05) and for the mean of the three measurements (0.14) were poor.

###### 

Descriptive statistics of creatinine-adjusted phthalate and bisphenol concentrations in urine samples measured in pregnancy.

Table 2, in 7 columns, lists variables, n, min, P25, P50, P75, and max.

  Variables                                                                                              $n$     Min    P25     P50     P75     Max
  ------------------------------------------------------------------------------------------------------ ------- ------ ------- ------- ------- -----------
  Phthalate metabolite concentrations ($\mu g/g\text{ creatinine}$)[^*a*^](#TF10){ref-type="table-fn"}                                          
   LMWP metabolites (weeks of gestation)                                                                                                        
    $< 18$                                                                                               1,274   0.4    109.5   239.5   603.3   102,789.2
    18--25                                                                                               1,270   4.3    46.8    102.6   238.0   36,050.2
    $> 25$                                                                                               1,269   21.1   103.0   232.3   530.5   8,131.3
   HMWP metabolites (weeks of gestation)                                                                                                        
    $< 18$                                                                                               1,274   0.6    39.6    68.5    126.6   2,837.4
    18--25[^*b*^](#TF11){ref-type="table-fn"}                                                            1,270   2.3    19.3    33.1    59.0    15,577.1
    $> 25$[^*b*^](#TF11){ref-type="table-fn"}                                                            1,269   3.6    35.0    52.3    81.9    1,683.6
   DEHP metabolites (weeks of gestation)                                                                                                        
    $< 18$                                                                                               1,274   0.3    31.4    55.2    103.0   2,821.2
    18--25                                                                                               1,270   1.8    14.4    25.0    46.3    15,574.4
    $> 25$                                                                                               1,269   3.2    29.6    45.0    71.0    1,673.5
   DNOP metabolites (weeks of gestation)                                                                                                        
    $< 18$                                                                                               1,274   0      0.9     1.6     2.8     106.5
    18--25                                                                                               1,270   0      0.4     0.8     1.4     65.8
    $> 25$                                                                                               1,269   0      1.2     1.9     3.0     72.0
   PA (weeks of gestation)                                                                                                                      
    $< 18$                                                                                               1,274   0.6    33.8    63.8    123.4   12,433.4
    18--25                                                                                               1,270   4.3    56.5    111.6   250.1   2,885.2
    $> 25$                                                                                               1,269   2.6    44.2    73.9    127.1   1,562.4
  Total bisphenol concentrations \[weeks of gestation ($\mu g/g\text{ creatinine}$)\]                                                           
   $< 18$[^*c*^](#TF12){ref-type="table-fn"}                                                             1,274   0.1    1.0     2.1     5.2     982.8
   18--25[^*d*^](#TF13){ref-type="table-fn"}                                                             1,270   0      0.6     1.2     2.5     277.6
   $> 25$[^*e*^](#TF14){ref-type="table-fn"}                                                             1,269   0.1    1.1     2.0     4.2     145.4

Note: Concentrations below the LOD were imputed with LOD divided by the square root of 2. DEHP, di-2-ethylhexylphthalate metabolite; DNOP, di-*n*-octylphthalate metabolite; HMWP, high-molecular weight phthalate metabolite; LMWP, low-molecular weight phthalate metabolite; LOD, limit of detection; max, maximum; min, minimum; P, percentile; PA, phthalic acid.

Phthalate metabolites are grouped into the following categories: LMWP metabolites (sum of mono-methyl phthalate, mono-ethyl phthalate, mono-isobutyl phthalate, and mono-$n$-butyl phthalate); HMWP metabolites \[sum of mono-(2-ethyl-5-carboxypentyl) phthalate, mono-(2-ethyl-5-hydroxyhexyl) phthalate, mono-(2-ethyl-5-oxohexyl) phthalate, mono-\[(2-carboxymethyl)hexyl\] phthalate, mono(3-carboxypropyl) phthalate, monobenzyl phthalate, mono-hexyl phthalate, and mono-2-heptyl phthalate; DEHP metabolites: \[sum of mono (2-ethyl-5 carboxypentyl)phthalate, mono (2-ethyl-5 hydroxyhexyl)phthalate, mono-(2-ethyl-5-oxohexyl)phthalate, and mono-\[(2-carboxymethyl)hexyl\]phthalate\]; DNOP metabolites \[mono(3-carboxypropyl) phthalate\]; and PA (a proxy for total phthalate exposure).

With the exclusion of mono-hexyl phthalate, and mono-2-heptyl phthalate metabolite concentrations.

Total bisphenol: sum of bisphenol A, bisphenol F, and bisphenol S.

Total bisphenol: sum of bisphenol A and bisphenol S.

Total bisphenol: sum of bisphenol A and bisphenol F.

Associations with Nonverbal IQ {#s3.3}
------------------------------

Creatinine-adjusted LMWP, DNOP, and PA metabolite concentrations at $< 18\text{ wks\ of\ gestation}$ were significantly associated with child nonverbal IQ score ([Table 3](#t3){ref-type="table"}). For example, a 10-fold higher LMWP, DNOP, or PA metabolite concentration was associated with lower nonverbal IQ scores of 1.7 points \[95% confidence interval (CI): $- 3.1$, $- 0.3$\], 2.0 points (95% CI: $- 3.7$, $- 0.2$), and 1.9 points (95% CI: $- 3.6$, $- 0.3$), respectively. The associations for HMWP \[$B = - 1.8$ (95% CI: $- 3.6$, 0.0)\], and DEHP \[$B = - 1.7$ (95% CI: $- 3.5$, 0.1)\] metabolite concentrations with nonverbal IQ were comparable in magnitude. When adjusted for mid and late pregnancy exposures, the associations of child nonverbal IQ with grouped phthalate metabolite concentrations were similar. Mid and late pregnancy concentrations of grouped phthalate metabolites were generally not significantly associated with nonverbal IQ. However, a 10-fold increase in DNOP metabolite concentration at $> 25\text{ wks}$ of gestation was associated with a 2.4-point lower nonverbal IQ score (95% CI: $- 4.8$, 0.0). Further, the significant interaction terms between LMWP, HMWP, DNOP, and PA metabolite concentrations and timing of exposure ($p = 0.06$, $p = 0.09$, $p = 0.03$, and $p = 0.05$, respectively) suggested that the potential effects of prenatal LMWP, HMWP, DNOP, and PA metabolite concentrations on nonverbal IQ might differ depending on the timing of exposure. No significant interaction terms were observed for DEHP metabolite concentrations and timing of exposure. Further, compared with the associations observed at $< 18\text{ wks}$ of gestation, we observed similar estimates in terms of magnitude for averaged LMWP \[$B = - 1.7$ (95% CI: $- 3.7$, 0.4)\] and PA \[$B = - 1.8$ (95% CI: $- 4.6$, 1.0)\] metabolite concentrations, and a greater estimate in terms of magnitude for averaged DNOP metabolite concentrations \[$B = - 3.0$ (95% CI: $- 6.0$, 0.0)\]. Finally, representative restrictive cubic splines for untransformed grouped phthalate metabolite concentrations at $< 18\text{ wks}$ of gestation and DNOP metabolite concentrations at $> 25\text{ wks}$ of gestation (see Figure S2) indicated a slightly steeper inverse association between exposure and outcome at lower levels of exposure.

###### 

Difference in child nonverbal IQ score at 6 years of age per $\log_{10}$ increase in creatinine-adjusted maternal urine phthalate metabolite and bisphenol concentrations (measured in micrograms per gram creatinine), by timing of urine sampling.

Table 3 has 4 main columns, namely, Phthalate metabolites superscript a and bisphenol concentrations, unadjusted, adjusted superscript b, and mutually adjusted superscript c. Unadjusted, adjusted superscript b, and mutually adjusted superscript c, each have two subcolumns, namely, B and 95 percent confidence interval.

  Phthalate metabolite[^*a*^](#TF16){ref-type="table-fn"} and bisphenol concentrations   Unadjusted   Adjusted[^*b*^](#TF17){ref-type="table-fn"}   Mutually adjusted[^*c*^](#TF18){ref-type="table-fn"}                                   
  -------------------------------------------------------------------------------------- ------------ --------------------------------------------- ------------------------------------------------------ -------------------- ---------- --------------------
  $\Sigma$ LMWP metabolites                                                                                                                                                                                                                
   $< 18\text{ wks}$ of gestation                                                        $- 3.21$     $- 4.64$, $- 1.78$                            $- 1.68$                                               $- 3.05$, $- 0.32$   $- 1.75$   $- 3.21$, $- 0.29$
   18--25 wks of gestation                                                               $- 1.70$     $- 3.30$, $- 0.11$                            0.27                                                   $- 1.25$, 1.79       1.04       $- 0.58$, 2.67
   $> 25\text{ wks}$ of gestation                                                        $- 2.85$     $- 4.52$, $- 1.18$                            $- 1.07$                                               $- 2.65$, 0.51       $- 0.80$   $- 2.50$, 0.90
   Averaged                                                                              $- 4.85$     $- 6.96$, $- 2.75$                            $- 1.68$                                               $- 3.72$, 0.36       ---        
   $p$-Value[^*d*^](#TF19){ref-type="table-fn"}                                                                                                                                                                                            0.06
  $\Sigma$ HMWP metabolites                                                                                                                                                                                                                
   $< 18\text{ wks}$ of gestation                                                        $- 3.63$     $- 5.55$, $- 1.70$                            $- 1.80$                                               $- 3.62$, 0.03       $- 1.98$   $- 3.82$, $- 0.13$
   18--25 wks of gestation[^*e*^](#TF20){ref-type="table-fn"}                            $- 0.87$     $- 2.81$, 1.07                                1.04                                                   $- 0.80$, 2.87       1.19       $- 0.67$, 3.05
   $> 25\text{ wks}$ of gestation[^*e*^](#TF20){ref-type="table-fn"}                     $- 0.14$     $- 2.82$, 2.54                                0.73                                                   $- 1.79$, 3.26       0.79       $- 1.76$, 3.33
   Averaged                                                                              $- 4.41$     $- 7.69$, $- 1.12$                            $- 0.37$                                               $- 3.52$, 2.78       ---        
   $p$-Value[^*d*^](#TF19){ref-type="table-fn"}                                                                                                                                                                                            0.09
  $\Sigma$ DEHP metabolites                                                                                                                                                                                                                
   $< 18\text{ wks}$ of gestation                                                        $- 3.20$     $- 5.09$, $- 1.31$                            $- 1.73$                                               $- 3.52$, 0.05       $- 1.89$   $- 3.69$, $- 0.09$
   18--25 wks of gestation                                                               $- 0.42$     $- 2.33$, 1.49                                0.92                                                   $- 0.88$, 2.72       1.06       $- 0.76$, 2.88
   $> 25\text{ wks}$ of gestation                                                        0.20         $- 2.38$, 2.77                                0.65                                                   $- 1.78$, 3.09       0.71       $- 1.75$, 3.16
   Averaged                                                                              $- 2.21$     $- 4.64$, 0.22                                0.05                                                   $- 2.26$, 2.36       ---        
   $p$-Value[^*d*^](#TF19){ref-type="table-fn"}                                                                                                                                                                                            0.11
  $\Sigma$ DNOP metabolites                                                                                                                                                                                                                
   $< 18\text{ wks}$ of gestation                                                        $- 2.61$     $- 4.46$, $- 0.76$                            $- 1.98$                                               $- 3.72$, $- 0.23$   $- 1.86$   $- 3.65$, $- 0.08$
   18--25 wks of gestation                                                               $- 0.13$     $- 2.20$, 1.94                                0.38                                                   $- 1.57$, 2.32       0.87       $- 1.1$, 2.84
   $> 25\text{ wks}$ of gestation                                                        $- 1.10$     $- 3.64$, 1.43                                $- 2.39$                                               $- 4.76$, $- 0.02$   $- 2.10$   $- 4.51$, 0.30
   Averaged                                                                              $- 3.28$     $- 6.47$, $- 0.09$                            $- 2.97$                                               $- 6.00$, 0.06       ---        
   $p$-Value[^*d*^](#TF19){ref-type="table-fn"}                                                                                                                                                                                            0.03
  PA metabolites                                                                                                                                                                                                                           
   $< 18\text{ wks}$ of gestation                                                        $- 2.59$     $- 4.32$, $- 0.87$                            $- 1.93$                                               $- 3.55$, $- 0.31$   $- 1.90$   $- 3.55$, $- 0.25$
   18--25 wks of gestation                                                               $- 0.90$     $- 2.72$, 0.91                                0.85                                                   $- 0.87$, 2.57       1.07       $- 0.66$, 2.80
   $> 25\text{ wks}$ of gestation                                                        $- 2.46$     $- 4.75$, $- 0.17$                            $- 1.09$                                               $- 3.25$, 1.07       $- 0.78$   $- 2.98$, 1.42
   Averaged                                                                              $- 4.64$     $- 7.57$, $- 1.71$                            $- 1.77$                                               $- 4.57$, 1.04       ---        
   $p$-Value[^*d*^](#TF19){ref-type="table-fn"}                                                                                                                                                                                            0.05
  Bisphenol metabolites                                                                                                                                                                                                                    
   $< 18\text{ wks}$ of gestation[^*f*^](#TF21){ref-type="table-fn"}                     0.38         $- 1.10$, 1.86                                0.49                                                   $- 0.90$, 1.87       0.48       $- 0.90$, 1.87
   18--25 wks of gestation[^*g*^](#TF22){ref-type="table-fn"}                            0.48         $- 1.19$, 2.15                                0.13                                                   $- 1.44$, 1.70       0.12       $- 1.44$, 1.69
   $> 25\text{ wks}$ of gestation[^*h*^](#TF23){ref-type="table-fn"}                     1.05         $- 0.74$, 2.85                                0.05                                                   $- 1.62$, 1.72       0.06       $- 1.61$, 1.74
   Averaged                                                                              1.81         $- 1.03$, 4.65                                0.76                                                   $- 1.89$, 3.42       ---        
   $p$-Value[^*d*^](#TF19){ref-type="table-fn"}                                                                                                                                                                                            0.92

Note: ---, not applicable; B, unstandardized beta; BMI, body mass index; CI, confidence interval; DEHP, di-2-ethylhexylphthalate; DNOP, di-$n$-octylphthalate; HMWP, high-molecular weight phthalate; IQ, intelligence quotient; LMWP, low-molecular weight phthalate; PA, phthalic acid.

Phthalate metabolites are grouped into the following categories: LMWP metabolites (sum of mono-methyl phthalate, mono-ethyl phthalate, mono-isobutyl phthalate, mono-$n$-butyl phthalate); HMWP metabolites \[sum of mono-(2-ethyl-5-carboxypentyl) phthalate, mono-(2-ethyl-5-hydroxyhexyl) phthalate, mono-(2-ethyl-5-oxohexyl) phthalate, mono-\[(2-carboxymethyl)hexyl\] phthalate, mono(3-carboxypropyl) phthalate, monobenzyl phthalate, mono-hexyl phthalate, and mono-2-heptyl phthalate\]; DEHP metabolites: \[sum of mono (2-ethyl-5 carboxypentyl) phthalate, mono (2-ethyl-5 hydroxyhexyl) phthalate, mono-(2-ethyl-5-oxohexyl) phthalate, and mono-\[(2-carboxymethyl)hexyl\] phthalate\]; DNOP metabolites \[mono(3-carboxypropyl) phthalate\]; and PA (a proxy for total phthalate exposure).

Adjusted for maternal age, maternal nonverbal IQ, sex of child, age of the child at assessment, ethnicity, education, income, marital status, maternal alcohol consumption, BMI, parity categories, and smoking.

Adjusted model with the inclusion of the three exposures in one model.

Tests whether exposure from different time points relates in the same manner to nonverbal IQ scores using the multiple informant method ([@c105]).

With the exclusion of mono-hexyl phthalate and mono-2-heptyl phthalate metabolite concentrations.

Total bisphenol: sum of bisphenol A, bisphenol F, and bisphenol S.

Total bisphenol: sum of bisphenol A and bisphenol S.

Total bisphenol: sum of bisphenol A and bisphenol F.

Effect Estimate Modification by Sex {#s3.4}
-----------------------------------

No effect estimate modification by sex was observed for the association between maternal urinary concentrations of grouped phthalate metabolite concentrations and nonverbal IQ (see Table S5). Similarly, there was no effect estimate modification by sex for the association between maternal urinary bisphenol concentrations and nonverbal IQ.

Sensitivity Analyses {#s3.5}
--------------------

First, the results with concentrations expressed as nanograms per milliliter and creatinine concentration added as a separate covariate were similar to the results of the main analyses using creatinine-corrected concentrations (see Table S6). Second, associations between individual urine phthalate metabolite concentrations at $< 18\text{ wks}$ of gestation and nonverbal IQ scores were inverse for all metabolites except for mHxP. Next, associations with mEP, mCMHP, and mCPP remained significant after confounder adjustment ([Figure 1](#f1){ref-type="fig"}; see also Table S7). For example, the mean nonverbal IQ score was 1.3 points lower (95% CI: $–2.4$, $–0.2$) in association with a 10-fold increase in urine mEP concentration at $< 18\text{ wks}$ of gestation. Most mid and late pregnancy concentrations of phthalate metabolites were not significantly associated with nonverbal IQ. However, a 10-fold increase mCPP metabolite concentrations at $> 25\text{ wks}$ of gestation was associated with a 2.4-point lower nonverbal IQ score (95% CI: $- 4.8$, 0.0). As compared with the associations observed at $< 18\text{ wks}$ of gestation, when we observed similar estimates in terms of magnitude for averaged mEP and mCMHP metabolite concentrations as well as a greater estimate in terms of magnitude for averaged mCPP metabolite concentrations. No associations were observed for the BPA, BPS, and BPF. Third, the results using inverse probability weighting to correct for potential selection bias (see Table S8) and the results in which we additionally adjusted for diet (see Table S9) were similar to the main results. Fourth, when the main results were corrected for the effective independent number of tests, the adjusted and mutually adjusted associations of maternal LMWP metabolite concentrations at $< 18\text{ wks\ of\ gestation}$ with nonverbal IQ remained significant. Similarly, the adjusted association between PA metabolite concentrations at $< 18\text{ wks\ of\ gestation}$ with nonverbal IQ survived the multiple testing correction.

![Difference in nonverbal IQ per $\log_{10}$ increase in phthalate metabolite concentrations in micrograms per gram creatinine at $< 18\text{ wks}$ of gestation. Corresponding numeric data are reported in Table S7. A) Unadjusted model. B) Adjusted for maternal age, maternal nonverbal IQ, sex of child, age of the child at assessment, ethnicity, education, income, marital status, maternal alcohol consumption, BMI, parity categories, and smoking categories. Note: BMI, body mass index; mBP, mono-*n*-butyl phthalate; mBzP, monobenzyl phthalate; mCMHP, mono-\[(2-carboxymethyl)hexyl\]phthalate; mCPP, mono(3-carboxypropyl) phthalate; mECPP, mono-(2-ethyl-5-carboxypentyl) phthalate; mEHHP, mono-(2-ethyl-5-hydroxyhexyl) phthalate; mEOHP, mono-(2-ethyl-5-oxyhexyl) phthalate; mEP, mono-ethyl phthalate; mHpP, mono-2-heptyl phthalate; mHxP, mono-hexyl phthalate; mIBP, mono-isobutyl phthalate; mMP, mono-methyl phthalate; PA, phthalic acid.](ehp6047_f1){#f1}

Discussion {#s4}
==========

In this large population-based study, we consistently observed that early pregnancy phthalate exposure was associated with lower child nonverbal IQ scores at 6 years of age. Urinary metabolite concentrations of early pregnancy LMWP, HMWP, DEHP, DNOP, and PA were associated with lower nonverbal IQ. We also found an inverse association between late pregnancy DNOP exposure and nonverbal IQ. Our findings did not support an association between other mid and late pregnancy grouped phthalate exposures, and we found little or no evidence of an association between prenatal bisphenol exposure and child nonverbal IQ. Finally, our results did not support effect modification by sex.

The results from our study may help clarify the so-far inconclusive results of epidemiological studies investigating the effect of prenatal exposure to phthalates on cognitive functioning. To our knowledge, most other previous studies have examined phthalate exposure during mid or late pregnancy. We did not find clear evidence for an association between mid and late pregnancy phthalate exposure and offspring IQ. Consistent with our results, previous studies have also found that prenatal phthalate metabolite concentrations measured at 14--27 wks of gestation ([@c61]), at 22--29 wks of gestation ([@c93]), and at 26--36 wks of gestation ([@c50]) were not associated with IQ score measured in children. Similarly, Li et al. ([@c74]) assessed the association between mid (range: 10--23 wks of gestation) and late pregnancy (19--35 wks of gestation) biomarkers of phthalate exposure and child IQ and did not find an association for most phthalate metabolite concentrations. However, they did report an inverse association for mid mBzP metabolite concentrations. Moreover, contrary to our results, several studies found third-trimester LMWP, DEHP, and HMWP exposure to be associated with cognition. A study demonstrated that a log-unit higher mBP and mIBP metabolite concentrations resulted in 2.7 lower IQ scores \[$\text{mBP} =$ ($- 2.7$, 95% CI: $- 4.3$, $- 1.1$), $\text{mIBP} =$ ($- 2.7$, 95% CI: $- 4.2$, $- 1.2$)\] in children 7 years of age ([@c37]). Other studies using the Bayles scales have estimated that higher DEHP and HMWP exposure was predictive of cognitive functioning in children 6 months to 3 years of age ([@c62]; [@c100]). In contrast to previous studies examining DNOP exposure in late pregnancy ([@c33]; [@c74]; [@c118]), we found an inverse association with late pregnancy mCPP metabolite concentrations and cognition. Differences in results may be due to ethnic differences and differences in cognitive measurement scales. For example, the study population of Factor-Litvak et al. ([@c37]) consisted of Hispanic and African American women of inner-city New York with low socioeconomic status. Our study population comprised mainly Dutch participants and fewer socioeconomically deprived persons, limiting comparability of the results. Further, the Bayley Scales of Infant Development measures cognition through evaluation of sensory perception, knowledge, memory, problem solving, and early language at a young age. We used the SON-R test to measure cognition at 6 years of age, which is an age when IQ is arguably more stable than in infants or toddlers.

Regarding bisphenols, our results are in line with those of previous studies that also were unable to detect an association between maternal urinary BPA concentrations and cognitive functioning in children ([@c16], [@c18]; [@c23]; [@c93]; [@c110]). BPA concentrations measured at 12 wks of gestation ([@c16]), at 16--26 wks of gestation ([@c18]; [@c110]), and at 22--29 wks of gestation ([@c93]) were not associated with IQ scores measured in children 1 and 8 years of age. Casas et al. ([@c23]) used the Bayley Scales (at 1 year of age) and the McCarthy Scales of Children's Abilities (at 4 years of age) to assess cognitive functioning but found no association for averaged first- and third-trimester BPA exposure. However, one study assessing BPA exposure using cord blood instead of maternal urine estimated an inverse association with IQ in children at 7 years of age ([@c77]).

To our knowledge, only one previous study investigated prenatal BPS and BPF exposure in relation to cognitive functioning in children ([@c115]). The present study examined early pregnancy exposure to a mixture of endocrine-disrupting chemicals, including BPA, BPF, and BPS, and identified BPF as the primary chemical with a substantial contribution to the overall mixture effect on lower IQ among boys ([@c115]). Manufacturers seeking BPA alternatives have turned to other bisphenols to produce BPA-free products ([@c43]). However, experimental studies have shown that the BPA replacements have metabolism, potencies, and mechanisms of action that may be similar to that of BPA ([@c34]). BPF and BPS also display endocrine-disruptive properties ([@c88]; [@c124]). Further, an experimental study suggested that prenatal BPS exposure is able to induce hypothalamic neurogenesis ([@c64]). However, we did not find that prenatal exposure to BPF and BPS was associated with nonverbal IQ in children.

Several studies have estimated sex differences in the association between prenatal phthalates or bisphenol exposure with neurobehavioral problems such as aggression, hyperactivity, inattention, emotional reactiveness, orientation, motor performance, anxiety, and depression and reduced masculine play in boys ([@c17], [@c15]; [@c36], [@c35]; [@c65]; [@c95]; [@c104]; [@c113]; [@c132]). In some studies of cognitive outcomes, effect modification by sex was estimated in the association of prenatal phthalate exposure and the Bayley Scales ([@c33]; [@c62]; [@c118]; [@c126]) and IQ ([@c51]), but the findings are inconsistent regarding the exact phthalate metabolites, timing of exposure, and the sex-specific effect of the associations.

The phthalate and bisphenol concentrations in the present study were generally of the same magnitude as those reported by several other studies of pregnant women. For example median mEHHP ($6–12\text{ ng}/{mL}$), mEOHP ($7–8\text{ ng}/{mL}$), mBP ($10–16\text{ ng}/{mL}$), and BPA ($1.1–1.5\text{ ng}/{mL}$) concentrations in the present study were similar to those estimated in Canada (9, 6, 12, and $1\text{ ng}/{mL}$, respectively) ([@c2]) and Israel (6, 5, 10, and $2\text{ ng}/{mL}$, respectively) ([@c80]). Concentrations measured in pregnant women from Korea, China, Taiwan, and the United States were, in general, somewhat higher ([@c37]; [@c51]; [@c61]; [@c62]; [@c100]; [@c126]; [@c128]). The difference in exposure levels between studies may be due to different dietary habits, methods and timing of urine sampling, product usage, and metabolic rate.

We found substantial confounding ($\sim 50\%$) of point estimates when adjusting for confounders and little change in the estimates when accounting for the exposure of other time windows. This suggests that the total effect of early pregnancy phthalate exposure on nonverbal IQ is mostly driven by the direct effect rather than by mid and late pregnancy phthalate exposure and that the effect of late pregnancy DNOP exposure is somewhat confounded by early and mid pregnancy exposure.

The critical windows of fetal neurodevelopment toxicity for phthalate exposure is uncertain. To the best of our knowledge, this is one of the first studies among humans that investigated early pregnancy phthalate exposure in relation to offspring IQ. Our results suggest that early pregnancy might be a critical period for potential effects of phthalate exposure on cognitive development. Although biological mechanisms that might contribute to associations are uncertain, animal studies have shown that phthalates may interfere with processes essential for the development of the fetal brain ([@c79]; [@c86]). A potential mechanism is via the disruption of the thyroid function ([@c79]; [@c86]). Thyroid hormones are important for fetal neurodevelopment from early pregnancy onward. Animal studies have showed that thyroid hormones are involved in neocorticogenesis and the development of the hippocampus and cytoarchitecture of the somatosensory cortex ([@c5]; [@c71]). In addition, data from animal studies have shown that maternal hypothyroxinemia interferes with neuronal migration, differentiation, synaptogenesis, and cortical layer formation ([@c90]; [@c94]). During early gestation, the fetus depends fully on maternal thyroid hormones that cross the placenta because the fetal thyroid function does not start before 12--14 wks of pregnancy ([@c90], [@c91]). Moreover, after the onset of fetal thyroid hormone production, the fetus remains dependent on maternal thyroid hormones ([@c90]). Prenatal exposure to phthalates has been associated with changes in circulating thyroid hormone and low thyroid function in pregnant women, including during early pregnancy ([@c40]; [@c58]; [@c70]; [@c131]), which is an important determinant of offspring neurodevelopment ([@c89]; [@c44]). For example, earlier studies in the same cohort as the present study (the Generation R Study cohort) found maternal thyroid function during early pregnancy to be associated with nonverbal IQ ([@c68]).

Another potential mechanism might be that prenatal phthalate exposure may affect neurodevelopment through interaction with peroxisome proliferator-activated receptors, a class of nuclear receptors involved in many physiologic processes central to neurodevelopment, including cellular reproduction and differentiation ([@c79]; [@c86]). Animal studies have shown that phthalates may induce peroxisome proliferator-activated receptor overexpression, resulting in apoptosis of undifferentiated neurons ([@c78]). Further, prenatal phthalate exposures may be associated with fetal growth ([@c82]), which is a strong predictor of neurodevelopment ([@c85]). It is conceivable that fetal exposure to phthalates may affect neurodevelopment via growth restriction. However, recent reviews do not provide a clear conclusion about the effects of phthalates on pregnancy outcomes such as gestational age, birth weight, and preterm birth ([@c82]; [@c103]; [@c133]). Several phthalates are anti-androgenic, resulting in circulating testosterone and male reproductive tract abnormalities ([@c39]; [@c45]; [@c48]; [@c59]; [@c101], [@c102]). Gonadal hormones are important for sex-specific brain development, and they also play a crucial role in adolescent brain remodeling ([@c27]; [@c30]). Other potential mechanisms include the disruption of calcium signaling and lipid metabolism, which are essential for normal neurodevelopmental processes in fetal life ([@c79]; [@c86]).

In the present study, we estimated that a 10-fold increase in early pregnancy phthalate metabolite concentrations and late pregnancy DNOP exposure was associated with 1.7--2.4 lower IQ points in children. Higher child IQ is associated with healthier behavior and lifetime achievements (including educational achievement, well-paid employment, enhanced social status, and the accompanying benefits to health) later in life ([@c7]; [@c129]). Several studies have estimated the socioeconomic impact of IQ loss. The burden and disease costs of exposure to chemicals has been estimated to be high ([@c121]). For example, every IQ point lost from the U.S. average is estimated to have an annual cost of $\text{US}\$ 71\text{ billion}$ ([@c92]).

A strength of the present study is the large sample size. The sample of our study was approximately two to three times larger than the abovementioned studies that investigated prenatal phthalates or bisphenol exposure and cognitive function in children. Another strength of the present study is the availability of more phthalate and bisphenol biomarkers as compared with previous studies investigating prenatal exposure to phthalates or bisphenols and neurodevelopment. Finally, the three repeated measures for exposure estimation in three time windows across pregnancy is yet another strength. This allowed us to investigate potential windows of susceptibility.

Our study has a few limitations that need to be considered. Although we adjusted for many potential confounders, we cannot rule out residual confounding by unknown unobserved background risk factors related to the likelihood of exposure and cognitive functioning. Second, we used three spot urine samples during early, mid, and late pregnancy for measurements of chemicals. Although this is more frequent than most other studies investigating prenatal exposure to phthalates and bisphenols and cognitive functioning, misclassification of exposure due to the limited number of samples may have occurred and could have resulted in less precise exposure--response estimates ([@c96]; [@c123]). This is particularly relevant for the time-specific analyses in which we relied on a single biomarker to estimate exposure. Phthalates and bisphenols have a short half-life and are quickly metabolized in the human body. Therefore, the use of multiple pooled urine specimens across trimesters is suggested to avoid exposure misclassification ([@c21]; [@c96]; [@c123]). Another limitation of the present study is the absence of information about the exact time of spot urine sampling. Because the urine spot samples were collected between 0800 and 1000 hours, there may have been a combination of first morning and random spot samples. Concentrations of chemicals, urine volume, and the rate of excretion vary with fluid intake, time of day, and other factors ([@c6]; [@c12]; [@c29]). Although, time of sample collection is unlikely to confound the association between phthalate and bisphenol exposure and nonverbal IQ, the difference in concentrations between morning and random spot urine could have increased the intra-individual variability. We used creatinine adjustment to account for urine dilution, which is advantageous because of its ease of measurement and the low cost and widespread availability of assays ([@c60]). However, creatinine excretion rates may vary across pregnancy ([@c25]; [@c31]; [@c32]), and studies have suggested that specific gravity rather than creatinine adjustment may be more appropriate in populations undergoing physiological changes in renal function, such as pregnant women ([@c1]; [@c81]). For example, specific gravity has a slightly better within-person reproducibility and the least amount of systematic variation when compared with creatinine adjustment ([@c81]). However, high correlations ($> 0.8$) between creatinine and specific gravity in spot urines have been reported ([@c20]; [@c28]; [@c107]). Finally, the Generation R Study is representative of an urban population with varying ethnicities, socioeconomic statuses, and educational levels, and therefore less generalizable to populations where the phthalate and bisphenol exposure sources may differ.

In the present study, we did not observe that maternal biomarkers of bisphenols are associated with lower nonverbal IQ. We did observe that phthalate exposure in early pregnancy and DNOP exposure in late pregnancy is associated with lower nonverbal IQ scores in children. Our results might suggest that particularly early pregnancy is a sensitive window of phthalate exposure, but future studies are needed to replicate our findings.

Supplementary Material
======================

###### 

Click here for additional data file.

###### 

Click here for additional data file.

The Generation R Study is conducted by the Erasmus Medical Center, Rotterdam, in close collaboration with the Faculty of Social Sciences of the Erasmus University Rotterdam, the Municipal Health Service, Rotterdam Homecare Foundation and Stichting Trombosedienst & Artsenlaboratorium Rijnmond. The authors extend thanks for the contribution of the participating parents and their children, general practitioners, hospitals, midwives, and pharmacies.

The general design of the Generation R Study is supported by the Erasmus Medical Center-Rotterdam, the Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development, Netherlands Organization for Scientific Research, and the Ministry of Health, Welfare and Sport, the Municipal Health Service Rotterdam area, and the Stichting Trombosedienst and Artsenlaboratorium Rijnmond. This research received financial support from National Institutes of Health (NIH) grants R01ES022972 and R01ES029779. In addition, this work was supported in part by the Intramural Research Program of the NIH/National Institute of Environmental Health Sciences (ZIAES101575). H.T. was supported by grants from Netherlands Organization for Scientific Research (NWO; grant 024.001.003, Consortium on Individual Development, and NWO/ZonMW grant 016.VICI.170.200). M.G. is funded by a Miguel Servet fellowship (MS13/00054, CPII18/00018) awarded by the Spanish Institute of Health Carlos III. The research leading to these results received funding from the European Union Horizon 2020 Research and Innovation Programme under grant 733206 (LifeCycle Project). A.G. was supported by grant UH3OD023305 from the Environmental influences on Child Health Outcomes Program (NIH). V.W.V.J. received grant ERC-2014-CoG-648916 from the European Research Council.
